Can EDTA improve the symptoms for Diabetics and how can we relate Diabetes and Chelation Therapy? For over half a century, Chelation Therapy has been used for many health issues. Chelation Therapy has been used to remove unwanted heavy metals (such as lead and mercury) and minerals from the human body, and has also been shown to provide many other secondary benefits.
The recently completed Tact study proved good news for Diabetes and Chelation Therapy
The TACT trials showed potentially important improvement in patients who had previous heart attacks and were already under cardiology treatment, especially those patients with diabetes. There were 18% fewer cardiac events in the treated group and 39% fewer cardiac events in diabetics. This is significant and cannot be ignored, indeed this is good news for diabetes and Chelation Therapy.
Types of Diabetes
There are primarily three types of diabetes: Type 1, Type 2, and gestational diabetes, each having different features and underlying causes.
Type 1 Diabetes: Usually starts during childhood or adolescence and is the result of an auto-immune attack on insulin producing beta cells in the pancreas. Consequently, individuals with Type 1 diabetes require lifelong insulin therapy to maintain blood glucose levels within a normal range.
Type 2 Diabetes: typically develops in adulthood and is largely influenced by lifestyle factors such as obesity, inactivity, and poor dietary habits. In this form of diabetes, the body either becomes resistant to insulin or fails to produce sufficient insulin to regulate blood sugar adequately.
Gestational Diabetes: occurs during pregnancy when hormonal changes affect insulin’s efficiency. While it usually resolves after childbirth, it can pose risks for both mother and baby and increases the likelihood of developing Type 2 diabetes later.
Key symptoms of diabetes include frequent urination (polyuria), excessive thirst (polydipsia), persistent fatigue, blurred vision, and unexplained weight loss. If left untreated, high blood sugar levels can lead to severe complications such as cardiovascular disease, nerve damage, kidney failure, and vision loss.
The risk factors for developing diabetes vary between types but often include age, family history, sedentary lifestyle, and unhealthy eating habits. The global prevalence of diabetes is on the rise, and the estimate is that over 400 million people live with the condition. Early diagnosis and management strategies, including lifestyle modifications and pharmaceutical interventions are necessary in minimizing the risk of diabetes and improving the quality of life.
Diabetes and EDTA Chelation
Emerging research states that chelation therapy has potential benefits for patients with diabetes.
Heavy metals like cadmium and lead can disrupt insulin function and interfere with glucose metabolism. Regular exposure to these metals has been associated with an increased risk of cardiovascular diseases which is a complication in diabetic patients. The rationale behind using chelation therapy is to eliminate the excess metals that contribute to insulin resistance and cardiovascular related issues.
One of the primary advantages of EDTA chelation is its ability to reduce oxidative stress, a significant factor contributing to the progression of diabetes. Oxidative stress occurs when there is an excess of free radicals in the body which leads to cellular damage. By utilising chelating agents that bind to heavy metals and other toxins it will assist in decreasing oxidative stress levels promoting better health outcomes for diabetic patients.
Furthermore, chelation therapy is believed to enhance insulin sensitivity. Insulin resistance is a common challenge for those with diabetes, making it difficult for the body to utilise glucose effectively. Several studies indicate that chelation treatment may improve insulin receptor sensitivity and allowing for more efficient glucose uptake. This potential improvement can lead to better glycemic control and a reduction in the long term complications typically associated with diabetes.
Cardiovascular Issues and Diabetes
Cardiovascular issues are prevalent amongst people with diabetes with heart disease being the leading cause. Chelation therapy is being as a method to help manage these risks by improving overall vascular health. Research indicates that EDTA can decrease arterial stiffness and enhance circulation, providing benefits that are especially important for those with diabetes. Patient testimonials have further illustrated these positive outcomes, including improved energy levels and decreased symptoms associated with vascular complications.
Chelation therapy holds many potential benefits for some diabetic patients, however it is important to be awarethat it should not replace standard diabetes practices determined by your Health care advisor. You should continue to adhere to their prescribed medications, monitor blood glucose levels, and implement the necessary lifestyle changes, including a balanced diet and regular exercise.
By increasing blood flow and removing heavy metals from the body, liquid chelation therapy from Cardio Renew can assist in relieving the symptoms of diabetes. Diabetes is one of the many health conditions Chelation has been used for.